FILE:DVA/DVA-8K-20070226144545.txt.gz
EVENTS:	Other Events	Financial Statements and Exhibits
TEXT:
ITEM: Other Events
ITEM: Financial Statements and Exhibits
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
 
 
 
 
Attached hereto as Exhibits 99.1 and 99.2 are copies of press releases issued by DaVita Inc. on February 23, 2007.
 
(d) Exhibits.
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 

Exhibit 99.1
 
El Segundo, California, February 23, 2007  DaVita Inc. (NYSE: DVA), today announced that it has completed the offering of $400 million aggregate principal amount of senior notes due in 2013. The senior notes are part of the same series of debt securities as the $500 million aggregate principal amount of 6
 5
/
8
% senior notes that were issued in March 2005. The senior notes and the senior subordinated notes ("the notes") were sold in an unregistered offering pursuant to Rule 144A and Regulation S under the Securities Act of 1933. The notes have not been registered under the Securities Act of 1933 or the securities laws of any state and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements under the Securities Act of 1933 and any applicable state securities laws. This announcement shall not constitute an offer to sell or the solicitation of an offer to buy the notes.
DaVita is a leading provider of dialysis services for patients suffering from chronic kidney failure. The Company provides services at kidney dialysis centers and home dialysis programs domestically in 42 states, as well as Washington, D.C. As of December 31, 2006, DaVita operated or managed approximately 1,300 outpatient facilities serving approximately 103,000 patients.
 

Exhibit 99.2
 
El Segundo, California, February 23, 2007 - DaVita Inc. (NYSE: DVA), today announced that it has amended its Senior Secured Credit Facilities to lower the applicable interest rates and modify certain financial covenants. Amended interest rates on the Term Loan B are LIBOR plus 1.50%. The interest rates on the outstanding Term Loan A and revolving credit facility remain unchanged.
The Company used the net proceeds of the recently completed senior note offering to repay $400 million of the outstanding Term Loan B loan. The outstanding balances under the amended credit facility include $279 million on the Term Loan A and $1.706 billion on the Term Loan B. In connection with these transactions the Company will be writing off approximately $4MM of deferred financing costs in the first quarter.
DaVita is a leading provider of dialysis services for patients suffering from chronic kidney failure. The Company provides services at kidney dialysis centers and home dialysis programs domestically in 42 states, as well as Washington, D.C. As of December 31, 2006, DaVita operated or managed approximately 1,300 outpatient facilities serving approximately 103,000 patients.
 


